I thought there was an effort to target a not-so-easy to change part of the virus. Maybe I’ve been dreaming. Either way the yearly shot, mRNA or otherwise is much more profitable so a one-and-done vaccine won’t appear out of Moderna of Pfizer, that’s for sure.
The whole not easy to change part can be a little misleading too. They originally thought that was the case with covid vaccines and it turned out that was not the case. Turns out when there’s pressure, sometimes things actually can happen.
As if the companies would think long term instead of yearly profit… whoever comes up with a one and done flu vaccine will see an enormous (if short) spike in profits and shareholders will want that spike to sell at the highest price possible and maybe get some dividends along the way.
I thought there was an effort to target a not-so-easy to change part of the virus. Maybe I’ve been dreaming. Either way the yearly shot, mRNA or otherwise is much more profitable so a one-and-done vaccine won’t appear out of Moderna of Pfizer, that’s for sure.
The whole not easy to change part can be a little misleading too. They originally thought that was the case with covid vaccines and it turned out that was not the case. Turns out when there’s pressure, sometimes things actually can happen.
As if the companies would think long term instead of yearly profit… whoever comes up with a one and done flu vaccine will see an enormous (if short) spike in profits and shareholders will want that spike to sell at the highest price possible and maybe get some dividends along the way.